![]() ![]() Until ICAN's suit, the v-safe data was not public, though specific findings have been reported by the CDC and medical journals. Representatives from Moderna and Johnson & Johnson did not respond to requests for comment. “This is a large and concerning number of negative health impacts,” Siri said of ICAN's conclusions, adding that he's aware of no comparable public data for other vaccines.Ī Pfizer media representative in an email said that the company’s vaccine has “a favorable safety profile and high level of protection against severe COVID-19 disease and hospitalization.” In addition, another CDC spokesperson said that agency personnel made follow-up calls to any v-safe users who reported seeking medical attention.īut ICAN counsel Aaron Siri of Siri & Glimstad, who led the FOIA litigation against the agency, said that because some vaccine-related adverse effects (chronic arthritis, thrombocytopenia, Guillain-Barré syndrome, myocarditis and more) can appear weeks after vaccination, it's important to broaden the time frame beyond the one-week window in research the CDC cited. She pointed me to a report looking at the first six months of v-safe data to back up the assertion. ![]() In the first week after getting the shot, the spokesperson continued, "reports of seeking any medical care (including telehealth appointments) range from 1-3% (depending on vaccine, age group and dose)." The CDC "cannot comment on analyses conducted outside of the agency that we have not seen," the spokesperson said via email, but added that v-safe data "have shown low rates of medical care after vaccination, particularly hospitalization." I asked a CDC spokesperson what the agency made of ICAN's calculations.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |